01/07 | Arbitrator Rules Employer's Two-Dose COVID Vaccine Requirement Not Reasonable (Anymore&.. |  |
01/07 | Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID |  |
01/07 | PFIZER : s'engage à réduire ses émissions carbonées |  |
01/07 | Pharmaceutical companies still have the upper hand |  |
01/07 | Pfizer Files New Drug Application For COVID-19 Antiviral Pill |  |
01/07 | U.S. FDA to use existing Omicron booster data to review shots targeting new subvariants.. |  |
30/06 | US FDA wants COVID boosters targeting Omicron BA.4, BA.5 subvariants |  |
30/06 | Tweaked COVID boosters in US must target newer omicron types |  |
30/06 | SECTOR UPDATE : Health Care Stocks Swoon Late, Closing Lower |  |
30/06 | SECTOR UPDATE : Health Care Stocks Little Changed on Thursday |  |
30/06 | Pfizer, BioNTech Enter $3.2 Billion Deal to Provide 105 Million COVID-19 Vaccines Doses.. |  |
30/06 | FDA bittet Impfstoffhersteller um Anpassung auf Omikron-Sublinien |  |
30/06 | PFIZER : Announces Commitment to Accelerate Climate Action and Achieve Net-Zero Standard b.. |  |
30/06 | Bye Bye H1, you won't be missed |  |
30/06 | AKTIEN NEW YORK AUSBLICK : Schwacher Handelstart - Ernüchternde Halbjahresbilanz |  |
30/06 | PFIZER/BIONTECH : nouveau contrat de 3,2 milliards de dollars pour le vaccin Covid-19 aux .. |  |
30/06 | HHS - Biden-Harris Administration secures 105 million doses of Pfizer's latest COVID-19.. |  |
30/06 | PFIZER : dépôt d'une demande à la FDA pour Paxlovid |  |
30/06 | LAUTERBACH : Cannabis-Freigabe mit dem Prinzip 'Safety first' |  |
30/06 | USA-Les valeurs à suivre à Wall Street (actualisé) |  |
30/06 | Pfizer Submits New Drug Application for Paxlovid |  |
30/06 | PFIZER : le gouvernement US commande 105M de vaccins Covid |  |
30/06 | Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID™ |  |
30/06 | Borse Europa, peggior trimestre da crollo pandemia a inizio 2020 |  |
30/06 | Hywin Holdings, FactSet Launch Global Health Care Index |  |
30/06 | Clap de fin pour un premier semestre tout pourri |  |
30/06 | Sirana Pharma Enters into Collaborative Research Agreement with Pfizer to Investigate N.. |  |
30/06 | EN DIRECT DES MARCHES : TotalEnergies, LVMH, OVH, CdA, Shell, Spirit, BioNTech... |  |
30/06 | Südkorea erteilt erstmals Zulassung für einheimischen Impfstoff |  |
30/06 | USA bestellen Pfizer/Biontech-Impfstoff für 3,2 Milliarden Dollar |  |
30/06 | Pfizer, BioNTech Sign New $3.2 Billion COVID-19 Vaccine Supply Deal With US |  |
30/06 | US buys 105 million COVID vaccine doses for fall campaign |  |
29/06 | Pfizer, BioNTech Enter $3.2 Billion Deal to Provide 105 Million COVID-19 Vaccines Doses.. |  |
29/06 | --STREET COLOR : Pfizer, BioNTech Reportedly Will Receive $3.2 Billion From US Government .. |  |
29/06 | Pfizer, BioNTech Reportedly Strike New Deal With US Government to Deliver Additional Do.. |  |
29/06 | Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional D.. |  |
29/06 | Pfizer Inc. and BioNTech SE Announces New Agreement with U.S. Government to Provide Add.. |  |
29/06 | Pfizer, BioNTech to Test Global Vaccine for COVID-19 |  |
29/06 | Pfizer, BioNTech To Start Tests On New Shots Targeting Coronaviruses |  |
29/06 | BioNTech, Pfizer to starting testing universal coronavirus vaccine in H2 |  |
29/06 | Trachoma Elimination - Millions More to Benefit From Donated Azithromycin |  |
29/06 | Anticipez la reprise avec ce mix d'ETFs (actions/obligations) |  |
28/06 | FDA advisers recommend updating COVID booster shots for fall |  |
28/06 | SECTOR UPDATE : Health Care |  |
28/06 | PFIZER : lance Priovant Therapeutics, avec Roivant Sciences |  |
28/06 | Pfizer, Roivant Sciences Launch New Joint Biotechnology Company Focused on Autoimmune D.. |  |
28/06 | Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for .. |  |
28/06 | Roivant Sciences and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Stu.. |  |
27/06 | SECTOR UPDATE : Health Care Stocks Posting Modest Monday Gains |  |
27/06 | AKTIEN NEW YORK : Dow stagniert bei steigenden Anleiherenditen |  |
27/06 | SECTOR UPDATE : Health Care Stocks Rising in Defensive Afternoon Trade |  |
27/06 | US grapples with whether to modify COVID vaccine for fall |  |
27/06 | Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Ana.. |  |
27/06 | Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate Hi.. |  |
27/06 | ++ Analysen des Tages von Dow Jones Newswires (27.06.2022) +++ |  |
27/06 | AKTIEN NEW YORK AUSBLICK : Dow und Nasdaq vor stabilem Start |  |
27/06 | PFIZER : nouvelles données d'étude positives dans la Covid |  |
27/06 | USA-Les valeurs à suivre à Wall Street (actualisé) |  |
27/06 | Pfizer-BioNTech COVID-19 Adapted Vaccines Show Higher Immune Response Against Omicron i.. |  |
27/06 | Will the Court require me to vaccinate my child against COVID-19? |  |
27/06 | Pfizer-BioNTech's Two Omicron-specific Vaccines Trigger High Immune Response Against CO.. |  |
26/06 | Neue Daten zu Omikron-Impfstoffen - Unmut über Zulassungspraxis |  |
26/06 | CORONA-BLOG/Biontech meldet wirksamen Impfstoff gegen Omikron-Varianten BA.4 und BA.5 |  |
25/06 | Pfizer says tweaked COVID-19 shots boost omicron protection |  |
25/06 | Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate Hi.. |  |
25/06 | Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate Hi.. |  |
24/06 | Meilleure séance en trois mois pour la Bourse de Paris |  |
24/06 | VALNEVA : plus forte baisse du marché SRD à la clôture du vendredi 24 juin 2022 - |  |
24/06 | VALNEVA : plus forte baisse du SBF 120 à la clôture du vendredi 24 juin 2022 - |  |
24/06 | U.S. CDC backs Moderna's COVID vaccine for teens, older children |  |
24/06 | Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Ana.. |  |
24/06 | Basilea Pharmaceutica announces approval for additional formulation of antifungal Crese.. |  |
24/06 | VALNEVA : stabilisation après l'envolée de jeudi |  |
24/06 | Novartis reçoit un avis positif européen pour Scemblix |  |
24/06 | Novartis Gets Positive Opinion from EU Medicines Agency Committee for Chronic Myeloid L.. |  |